Immuneering Corporation (IMRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -18.43M | -9.84M | -11.98M | -9.45M | -14.08M | -14.51M | -13.47M | -11.53M | -15.49M | -11.78M | -12.03M | -10.75M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -30.91% | 32.18% | 11.1% | 18.04% | 9.11% | -23.23% | -12.02% | -7.23% | -7.44% | -0.23% | -13.22% | -13.75% |
| Net Income | -13.46M | -11.58M | -14.96M | -14.43M | -15.05M | -18.05M | -14.6M | -14.08M | -14.31M | -15.08M | -12.6M | -12.19M |
| Depreciation & Amortization | 180.48K | 172.65K | 86.16K | 91.84K | 92.58K | 174.65K | 96.27K | 97.85K | 187.68K | 185.22K | 195.78K | 193.51K |
| Stock-Based Compensation | 0 | 0 | 0 | 1.52M | 1.69M | 0 | 1.64M | 1.66M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.23M | 1.48M | 1.54M | 85.2K | 83.18K | 1.67M | 46.55K | 69.92K | 1.31M | 1.24M | 1.17M | 1.22M |
| Working Capital Changes | -6.38M | 82.57K | 1.36M | 3.29M | -902.53K | 1.69M | -657.59K | 724.49K | -2.68M | 1.88M | -794.68K | 27.06K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -89.58K | 73.42K | -974.89K | 1.19M | -687.87K | 56.74K | -679.45K | 393.18K | 117.39K | 170.57K | -778.2K | -68.33K |
| Cash from Investing | -63.07M | -88.72M | -7.25K | -2.12K | -8.95K | 5.49M | -5.42M | 4.97M | 21.39M | 3.13M | -23.97M | 9.16M |
| Capital Expenditures | -79.93K | -123.91K | -7.25K | -2.12K | -8.95K | -9.36K | -5.27K | -32.77K | -37.48K | -170.92K | -57.15K | -86.69K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -5.41M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 180.76K | -357.52K | 213.19M | -61.96K | 13.81M | -40.99K | 4.36M | 0 | 979.92K | 7.83K | 21.45K | 28.17M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 180.76K | -357.52K | 213.19M | -61.96K | 13.68M | -415.64K | 4.24M | 0 | 979.92K | 7.83K | 21.45K | 28.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 133.89K | 374.65K | 127.19K | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -81.32M | -98.92M | 201.21M | -9.51M | -279.02K | -9.06M | -14.52M | -6.56M | 6.88M | -8.63M | -35.98M | 26.59M |
| Free Cash Flow | -18.51M | -9.96M | -11.98M | -9.45M | -14.09M | -14.52M | -13.48M | -11.56M | -15.53M | -11.95M | -12.08M | -10.84M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -31.4% | 31.37% | 11.08% | 18.26% | 9.27% | -21.54% | -11.53% | -6.68% | -7.49% | -1.08% | -9.7% | -12.7% |
| FCF per Share | -0.42 | -0.23 | -0.30 | -0.26 | -0.40 | -0.47 | -0.45 | -0.39 | -0.53 | -0.41 | -0.41 | -0.38 |
| FCF Conversion (FCF/Net Income) | 1.37x | 0.85x | 0.80x | 0.65x | 0.94x | 0.80x | 0.92x | 0.82x | 1.08x | 0.78x | 0.95x | 0.88x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |